{"entity":{"id":"nct05806060","kind":"trial","name":"Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer","aka":["BCTOP-T-M01"],"tldr":"A phase 3 trial in triple-negative breast cancer, run by Fudan University, now recruiting.","summary":"Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer is a phase 3, randomised interventional study registered as NCT05806060 by Fudan University, with a registry enrolment figure of 134 participants, started 2023-04-25 and due to reach its primary completion in 2026-05-01. Interventions recorded: VEGFR and TPC; TPC. Conditions listed: Triple-Negative Breast Cancer. Triple-negative eligibility wording from the registry: \"* Metastatic or locally advanced, histologically documented TNBC (absence of HER2, ER, and PR expression) with BLIS subtype\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05806060","url":"https://clinicaltrials.gov/study/NCT05806060"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-metastatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05806060","phase":"3","setting":"Precise Treatment for BLIS Subtype of Triple-negative Breast Cancer in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer","sponsor":"Fudan University","enrolled":134,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05806060/","neighbours":{"cancer":[{"id":"tnbc-metastatic","kind":"cancer","name":"Metastatic triple-negative breast cancer","route":"/cancers/tnbc-metastatic/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}